DeepMind’s Latest A.I. Health Breakthrough Has Some Problems
The Google machine learning company trumpeted its success in predicting a deadly kidney condition, but its results raise questions around data rights and patient diversity
Google-affiliated artificial intelligence firm DeepMind has been pushing into the healthcare sector for some time. Last week the London-based company synchronized the release of a set of new research articles — one with the U.S. Department of Veterans Affairs, and three with a North London hospital trust known as the Royal Free.
In one paper, published in the journal Nature, with co-authors from Veterans Affairs and University College London, DeepMind claimed its biggest healthcare breakthrough to date: that artificial intelligence (A.I.) can predict acute kidney injury (AKI) up to two days before it happens.
AKI — which occurs when the kidneys suddenly stop functioning, leading to a dangerous buildup of toxins in the bloodstream — is alarmingly common among hospital patients in serious care, and contributes to hundreds of thousands of deaths in the United States each year. DeepMind’s bet is that if it can successfully predict which patients are likely to develop AKI well in advance, then doctors could stop or…
